Dual effects of 3,4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons

被引:0
|
作者
Abolfazl Azami
Parichehr Pasbakhsh
Mohammad Akbari
Mohammad Barbarestani
Mohammadhosein Ghahremani
Mohammadali Shokrgozar
Ali Mandegary
Amir Kiani
Gholamreza Hassanzadeh
机构
[1] School of Pharmacy,Kermanshah University of Medical Scences
[2] Department of Anatomy,School of Medicine,Tehran University of Medical Sciences
[3] National Cell Bank of Iran,Pasteur Institute of Iran
[4] Department of Toxicology-Pharmacology,Faculty of Pharmacy,Tehran University of Medical Sciences
关键词
3,4-methylenedioxymethamphetamine; ecstasy; apoptosis; N-methyl-D-aspartate; neuronal culture;
D O I
暂无
中图分类号
R363 [病理生理学];
学科分类号
100104 ;
摘要
BACKGROUND: 3, 4-methylenedioxymethamphetamine (MDMA, also known as "ecstasy") hasbeen shown to exhibit neurotoxic effects on the hippocampus. However, exposure to sub-lethalinsults of MDMA has been reported to result in neuroprotection.OBJECTIVE: To investigate the effects of MDMA on hippocampal neuronal viability, caspase-3activity, and mRNA expression of the N-methyl-D-aspartate (NMDA) receptor 2B (NR2B) subunit.DESIGN, TIME AND SETTING: A cytological, in vitro experiment was performed at the Departmentof Anatomy, School of Medicine, and Department of Toxicology-Pharmacology, Faculty of PharmacyTehran University of Medical Sciences in 2008.MATERIALS: MDMA was extracted from ecstasy tablets, which were kindly supplied by thePharmacology-Toxicology Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran.METHODS: Hippocampal neurons were isolated from Wistar rats at gestational day 18. Followingprimary culture, hippocampal neuronal viability was detected by MTT assay. Varying concentrationsof MDMA (100 5 000 μmol/L) were used to determine lethal concentration 50 (LC50), which wasaround 1 500 μmol/L. Five concentrations of MDMA below 1 500 μmol/L (100, 200, 400, 800, and1 050 μmol/L) were used for the remaining experiments. After 24 hours of MDMA treatment,NR2B mRNA expression was detected by RT-PCR, and caspase-3 relative activity was determinedby colorimetric assay.MAIN OUTCOME MEASURES: Hippocampal neuronal viability, caspase-3 activity, andNR2B mRNA expression.RESULTS: MDMA-induced neurotoxicity in hippocampal neuronal cultures was dose-dependent. Inhigh concentrations (1 000-5 000 μmol/L) of MDMA, neuronal viability was decreased. However,with a 500 μmol/L dose of MDMA, neuronal viability was significantly increased (P < 0.01). Lowconcentrations of MDMA (200 and 400 μmol/L) significantly decreased caspase-3 activity (P < 0.01),whereas high concentrations of MDMA significantly increased caspase-3 activity (P < 0.01). NR2Bsubunit mRNA expression was not significantly altered after 100 1 050 μmol/L MDMA exposure.CONCLUSION: MDMA exhibits dual effects on hippocampal neuronal viability and caspase-3activitv. These effects are independent from NR2B subunit expression levels.
引用
收藏
页码:1068 / 1072
页数:5
相关论文
共 50 条
  • [21] Is Ecstasy an "Empathogen"? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others
    Bedi, Gillinder
    Hyman, David
    de Wit, Harriet
    BIOLOGICAL PSYCHIATRY, 2010, 68 (12) : 1134 - 1140
  • [22] Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users
    Parrott, A. C.
    NEUROPSYCHOBIOLOGY, 2009, 60 (3-4) : 148 - 158
  • [23] 3,4-methylenedioxymethamphetamine (Ecstasy)-induced hepatotoxicity: Multidetector CT and pathology findings
    Lawler, LP
    Abraham, S
    Fishman, EK
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2001, 25 (04) : 649 - 652
  • [24] Recreational 3,4-methylenedioxymethamphetamine or "ecstasy': Current perspective and future research prospects
    Parrott, Andrew C.
    Downey, Luke A.
    Roberts, Carl A.
    Montgomery, Cathy
    Bruno, Raimondo
    Fox, Helen C.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (08) : 959 - 966
  • [25] REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)
    GREEN, AR
    CROSS, AJ
    GOODWIN, GM
    PSYCHOPHARMACOLOGY, 1995, 119 (03) : 247 - 260
  • [26] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335
  • [27] Binge administration of 3,4-methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus
    Hernandez-Rabaza, V.
    Dominguez-Escriba, L.
    Barcia, J. A.
    Rosel, J. F.
    Romero, F. J.
    Garcia-Verdugo, J. M.
    Canales, J. J.
    NEUROPHARMACOLOGY, 2006, 51 (05) : 967 - 973
  • [28] Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood:: evidence of gender differences
    Verheyden, SL
    Hadfield, J
    Calin, T
    Curran, HV
    PSYCHOPHARMACOLOGY, 2002, 161 (01) : 23 - 31
  • [29] Validating the consumption of MDMA (3,4-methylenedioxymethamphetamine) in an examination of the behavioural effects of "ecstasy" amongst recreational users
    Sherlock, K
    Hay, AWM
    Wolff, K
    Conner, M
    ADDICTION RESEARCH, 1999, 7 (01): : 47 - 62
  • [30] Prenatal Exposure to Alcohol and 3,4-Methylenedioxymethamphetamine (Ecstasy) Alters Adult Hippocampal Neurogenesis and Causes Enduring Memory Deficits
    Canales, Juan J.
    Ferrer-Donato, Agueda
    DEVELOPMENTAL NEUROSCIENCE, 2014, 36 (01) : 10 - 17